Advertisement

Intensity Modulated Radiotherapy in Cancer of the Larynx

  • M. T. Guerrero Urbano
  • C. H. Clark
  • M. Bidmead
  • D. P. Dearnaley
  • K. J. Harrington
  • C. M. Nutting

Keywords

Planning Target Volume Radiat Oncol Biol Phys Intensity Modulate Radiotherapy Clinical Target Volume Dose Volume Histogram 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Adelstein DJ (1998) Recent randomised trial of chemoradiation in the management of locally advanced head and neck cancer. Curr Opin Oncol 10:213–218PubMedGoogle Scholar
  2. 2.
    Annyas AA et al. (1979) Prognostic factors of neck node metastasis: their impact on planning a treatment regimen. American Society of Head and Neck Surgeons, Los AngelesGoogle Scholar
  3. 3.
    Bataini JP et al. (1985) Natural history of neck disease in patients with squamous cell carcinoma of oropharynx and pharyngolarynx. Radiother Oncol 3:245–255PubMedGoogle Scholar
  4. 4.
    Bourhis J et al. (2002) Conventional versus modified fractionated radiotherapy: meta-analysis based on individual data of patients with head and neck squamous cell carcinoma (HNSCC). Radiother Oncol 64(suppl.1):S23Google Scholar
  5. 5.
    Braaksma MMJ et al. (2003) Optimisation of conformal radiation therapy by intensity modulation: cancer of the larynx and salivary gland function. Radiother Oncol 66:291–302PubMedCrossRefGoogle Scholar
  6. 6.
    Bragg CM et al. (2002) The role of intensity-modulated radiotherapy in the treatment of parotid tumors. Int J Radiat Oncol Biol Phys 52(3)729–738PubMedCrossRefGoogle Scholar
  7. 7.
    Burke LS et al. (1997) Definitive radiotherapy for early glottic carcinoma: prognostic factors and implications for treatment. Int J Radiat Oncol Biol Phys 38:37–42PubMedCrossRefGoogle Scholar
  8. 8.
    Butler EB et al. (1999) Smart (simultaneous modulated accelerated radiation therapy) boost: a new accelerated fractionation schedule for the treatment of head and neck cancer with intensity modulated radiotherapy. Int J Radiat Oncol Biol Phys 45:21–32PubMedCrossRefGoogle Scholar
  9. 9.
    Byers et al. (1988) Rationale for elective modified neck dissection. Head Neck Surg 10:160–167PubMedGoogle Scholar
  10. 10.
    Candela et al. (1998) Patterns of cervical node metastases from squamous cell carcinoma of the oropharynx and hypopharynx. Head Neck 12:197–203Google Scholar
  11. 11.
    Carter et al. (1987) Radical neck dissections for squamous carcinomas: pathological findings and their clinical implications with particular reference to transcapsular spread. Int J Radiat Oncol Biol Phys 13:825–832PubMedGoogle Scholar
  12. 12.
    Chao KS et al. (2002) Determination and delineation of nodal target volumes for head and neck cancer based on patterns of failure in patients receiving definitive and postoperative IMRT. Int J Radiat Oncol Biol Phys 53(5):1174–1184PubMedCrossRefGoogle Scholar
  13. 13.
    Clark CH et al. (2004) Intensity modulated radiotherapy improves target coverage, spinal cord sparing and allows dose escalation in patients with locally advanced cancer of the larynx. Radiother Oncol 70(2):189–198PubMedCrossRefGoogle Scholar
  14. 14.
    Claus F et al. (2001) Evaluation of a leaf position optimisation tool for intensity modulated radiation therapy of head and neck cancer. Radiother Oncol 61:281–286PubMedCrossRefGoogle Scholar
  15. 15.
    Das S et al. (2003) Beam orientation selection for intensity-modulated radiation therapy based on target equivalent uniform dose maximization. Int J Radiat Oncol Biol Phys 55(1):215–224PubMedCrossRefGoogle Scholar
  16. 16.
    De Neve W et al. (1996) Planning and delivering high doses to targets surrounding the spinal cord at the lower neck and upper mediastinal levels: static beam-segmentation technique executed by a multileaf collimator. Radiother Oncol 40: 271–279PubMedCrossRefGoogle Scholar
  17. 17.
    El-Sayed S, Nelson N (1996) Adjuvant and adjunctive chemotherapy in the management of squamous cell carcinoma of the head and neck region: a meta-analysis of prospective and randomised trials. J Clin Oncol 14:838–847PubMedGoogle Scholar
  18. 18.
    Eisbruch et al. (2002) Intensity modulated radiation therapy for head and neck cancer: emphasis on the selection and delineation of targets. Semin Radiat Oncol 12(3):238–249PubMedCrossRefGoogle Scholar
  19. 19.
    Emami B et al. (1991) Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 21(1):109–122PubMedGoogle Scholar
  20. 20.
    Fletcher GH, Goepfert H (1980) Larynx and hypopharynx. In: Fletcher G (ed) Textbook of radiotherapy. Lea & Febiger, Philadelphia, pp 330–363Google Scholar
  21. 21.
    Forastiere AA et al. (2003) Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 349(22):2091–2098PubMedCrossRefGoogle Scholar
  22. 22.
    Fu KK et al. (2000) Radiation Therapy Oncology Group(RTOG) phase III randomised study to compare hyperfractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. Int J Radiat Oncol Biol Phys 48:7–16PubMedCrossRefGoogle Scholar
  23. 23.
    Gallo O et al. (2000) Treatment of the contralateral negative neck in supraglottic cancer patients with unilateral node metastases (N1-N3). Head Neck 22:386–392PubMedCrossRefGoogle Scholar
  24. 24.
    Gowda RV et al. (2003) Three weeks radiotherapy for T1 glottic cancer: the Christie and Royal Marsden Hospital experience. Radiother Oncol 68:105–111PubMedCrossRefGoogle Scholar
  25. 25.
    Gregoire et al. (2003) CT-based delineation of lymph node levels and related CTVs in the node negative enck: DAHANCA, EORTC, GORTEC, NCIC, RTOG consensus guidelines. Radiother Oncol 69:227–236PubMedCrossRefGoogle Scholar
  26. 26.
    Guerrero Urbano MT, Nutting CM (2004) Clinical use of intensity-modulated radiotherapy: part I. Br J Radiol 77(914):88–96PubMedCrossRefGoogle Scholar
  27. 27.
    Harwood A et al. (1983) Supraglottic laryngeal carcinoma: an analysis of dose-time-volume factors in 410 patients. Int J Radiat Oncol Biol Phys 9:311PubMedGoogle Scholar
  28. 28.
    Harwood A et al. (1979) Management of advanced glottic cancer: a 10-year review of the Toronto experience. Int J Radiat Oncol Biol Phys 5:899PubMedGoogle Scholar
  29. 29.
    Hermanek P et al. (1997) UICC TNM atlas, 4th ednGoogle Scholar
  30. 30.
    Hicks WL et al. (1999) Patterns of nodal metastasis and surgical management of the neck in supraglottic laryngeal carcinoma. Otolaryngol Head Neck Surg 121:57–61PubMedCrossRefGoogle Scholar
  31. 31.
    Hirabayashi et al. (1991) Extracapsular spread of squamous cell carcinoma in the neck lymph nodes: prognostic factor of laryngeal cancer. Laryngoscope 101:502–506PubMedGoogle Scholar
  32. 32.
    Horiot JC et al. (1997) Accelerated fractionation (AF) compared to conventional fractionation (CF) improves locoregional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22581 randomised trial. Radiother Oncol 44:111–121PubMedCrossRefGoogle Scholar
  33. 33.
    Huang et al. (1992) Postoperative radiotherapy in head and neck carcinoma with extracapsular lymph node extension and/or positive resection margins. A comparative study. Int J Radiat Oncol Biol Phys 23:737–742PubMedGoogle Scholar
  34. 34.
    Humphreys M et al. (2003) Assessment of treatment accuracy for head and neck intensity modulated radiotherapy (IMRT) and conventional radiotherapy using amorphous silicon portal imaging. Radiother Oncol 68:S65Google Scholar
  35. 35.
    ICRU 50 (1993) Prescribing, recording and reporting photon beam therapy ICRU report 50. International Commission on Radiation Units and Measurement, BethesdaGoogle Scholar
  36. 36.
    ICRU 62 (1999) Prescribing, recording and reporting photon beam therapy (supplement to ICRU Report 50). International Commission on Radiation Units and Measurement, BethesdaGoogle Scholar
  37. 37.
    Johansen LV et al. (2002) Supraglottic carcinoma: patterns of failure and salvage treatment after curatively intended radiotherapy in 410 consecutive patients. Int J Radiat Oncology Biol Phys 53:948–958CrossRefGoogle Scholar
  38. 38.
    Johnson et al. (1981) The extracapsular spread of tumours in cervical node metastasis. Arch Otolaryngol 107:725–729PubMedGoogle Scholar
  39. 39.
    Lee N et al. (2002) Skin toxicity due to intensity modulated radiotherapy for head-and-neck carcinoma Int J Radiat Oncol Biol Phys 53(3)630–637PubMedCrossRefGoogle Scholar
  40. 40.
    Lee N et al. (2003) Intensity-modulated radiation therapy for head-and-neck cancer: the UCSF experience focusing on target volume delineation. Int J Radiat Oncology Biol Phys 57(1):49–60CrossRefGoogle Scholar
  41. 41.
    Lindberg R (1972) Distribution of cervical lymph node metastases from squamous cell carcinoma of the upper respiratory and digestive tracts. Cancer 29:1446–1449PubMedGoogle Scholar
  42. 42.
    Maciejewski B et al. (1983) The influence of the number of fractions and of overall treatment time on local control and late complication rate in squamous cell carcinoma of the larynx. Int J Radiat Oncol Biol Phys 9:321–328PubMedGoogle Scholar
  43. 43.
    McLaughlin et al. (1995) Retropharyngeal adenopathy as a predictor of outcome in squamous cell carcinoma of the head and neck. Head Neck 17:190–198PubMedGoogle Scholar
  44. 44.
    Mendenhall WM et al. (2001) T1-T2 squamous cell carcinoma of the glottic larynx treated with radiation therapy. J Clin Oncol 19:4029–4036PubMedGoogle Scholar
  45. 45.
    Mendenhall W et al. (1992) Stage T3 squamous cell carcinoma of the glottic larynx: a comparison of laryngectomy and irradiation. Int J Radiat Oncol Biol Phys 23(4):725–732PubMedGoogle Scholar
  46. 46.
    Mendenhall WM et al. (1989) Is elective neck treatment indicated for T2N0 squamous cell carcinoma of theglottic larynx? Radiother Oncol 14:199–202PubMedCrossRefGoogle Scholar
  47. 47.
    Miles EA et al. (2003) How routine can IMRT become in daily clinical practice? Radiother Oncol 68:S121Google Scholar
  48. 48.
    Mohan R et al. (2000) Radiobiological considerations in the design of fractionation strategies for intensity-modulated radiation therapy of head and neck cancers. Int J Radiat Oncol Biol Phys 46:619–630PubMedCrossRefGoogle Scholar
  49. 49.
    Nutting CM et al. (2001) Optimisation of radiotherapy for carcinoma of the parotid gland: a comparison of conventional, three-dimensional conformal and intensity-modulated techniques Radiother Oncol 60:163–172PubMedCrossRefGoogle Scholar
  50. 50.
    Overgaard J et al. (2003) Five compared with six fractions per week of conventional radiotherapy of squamous cell carcinoma of the head and neck: DAHANCA 6 and 7 randomised controlled trial. Lancet 362:933–940PubMedCrossRefGoogle Scholar
  51. 51.
    Paisley S et al. (2002) Results of radiotherapy for primary sub-glottic squamous cell carcinoma. Int J Radiation Oncol Biol Phys 52:1245–1250CrossRefGoogle Scholar
  52. 52.
    Pignon JP et al. (2000) Chemotherapy added to locoregional treatment for head and neck squamous cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-analysis of chemotherapy on head and neck cancer. Lancet 355:949–955PubMedGoogle Scholar
  53. 53.
    Rowbottom CG et al. (2001) Beam-orientation optimization of intensity-modulated radiotherapy: clinical application to parotid gland tumors. Radiother Oncol 59:169–177PubMedCrossRefGoogle Scholar
  54. 54.
    Shah et al. (1990) The patterns of cervical lymph node meatastases from squamous carcinoma of the oral cavity. Cancer 66:109–113PubMedGoogle Scholar
  55. 55.
    Sessions DG et al. (1975) Carcinoma of the subglottic area. Laryngoscope 4:618–636Google Scholar
  56. 56.
    Spriano G et al. (1997) Conservative management of T1-T2N0 supraglottic cancer: a retrospective study. Am J Otoralyngol 18:299–305CrossRefGoogle Scholar
  57. 57.
    The Department of Veteran Affairs Laryngeal Cancer Study Group (1991) Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N England J Med 324:1685–1690CrossRefGoogle Scholar
  58. 58.
    Tomik J et al. (2001) Evaluation of cervical lymph node metastasis of 1400 patients with cancer of the larynx. Auris Nasus Larynx 28:233–240PubMedCrossRefGoogle Scholar
  59. 59.
    van Asselen B et al. (2002) The dose to the parotid glands with IMRT for oropharyngeal tumors: the effect of reduction of positioning margins. Radiother Oncol 64:197–204PubMedCrossRefGoogle Scholar
  60. 60.
    van Dieren EB et al. (2000) Beam intensity modulation using tissue compensators or dynamic multileaf collimation in three dimensional conformal radiotherapy of primary cancers of the oropharynx and larynx, including the elective neck. Int J Radiation Oncology Biology and Physics 47(5): 1299–1309CrossRefGoogle Scholar
  61. 61.
    Withers HR et al. (1988) The hazard of accelerated tumour clonogens repopulation during radiotherapy. Acta Oncol 27:131–146PubMedGoogle Scholar
  62. 62.
    Wu Q et al. (2000) The potential for sparing of parotids and escalation of biologically effective dose with intensity-modulated radiation treatments of head and neck cancers: a treatment design study. Int J Radiat Oncol Biol Phys 46:195–205PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2006

Authors and Affiliations

  • M. T. Guerrero Urbano
    • 1
  • C. H. Clark
    • 1
  • M. Bidmead
    • 1
  • D. P. Dearnaley
    • 1
  • K. J. Harrington
    • 1
  • C. M. Nutting
    • 1
  1. 1.Head and Neck UnitRoyal Marsden Hospital and Institute of Cancer ResearchLondonUK

Personalised recommendations